Daily non-political popular news in brief.

Personal drug selection: Problem-based learning in pharmacology

Irrational use of medicines is a major problem all over the world. The World Health Organization and many other bodies are concentrating on improving the use of medicines. Problem-based teaching of Pharmacology and therapeutics to undergraduate medical students has been recognized as a key intervention to improve the use of medicines.

Read more »

Keywords: personal, drug, selection, problem-based, learning, pharmacology, problem, based

« Previous | Next »

Similar news on "Personal drug selection: Problem-based learning in pharmacology":

1. Sound training rewires dyslexic children's brains for reading
   10-30-2007 · EurekAlert!
   Brain imaging adds further support to the idea that at least some children with dyslexia have trouble processing sound, rather than a visual problem. The study also shows that computer-based sound training exercises can not only improve reading but literally rewire the brain. The findings may help clinicians detect and remediate dyslexia even before children begin learning to read.
   Similar news · Read more »
   
2. Genes and drugs team up to lower blood pressure
   09-12-2007 · EurekAlert!
   Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.
   Similar news · Read more »
   
3. Combining medications often best strategy to battle rheumatoid arthritis
   11-19-2007 · EurekAlert!
   For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center.
   Similar news · Read more »
   
4. Researchers study effects of Aricept in pediatric brain cancer survivors
   11-03-2006 · EurekAlert!
   A pediatric oncologist at Brenner Children's Hospital is evaluating whether a drug typically used to treat Alzheimer's patients will help brain cancer survivors avoid the learning and memory problems that are common after radiation therapy.
   Similar news · Read more »
   
5. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
   06-27-2007 · EurekAlert!
   New research carried out by researchers in Nepal has shown that a new and affordable drug, gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organization. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem. The results are published in the June 27 issue of the online, open-access journal PLoS ONE.
   Similar news · Read more »
   
6. Liver fibrosis will be treated by a potential target
   10-16-2007 · EurekAlert!
   The hepatitis is either self recovery or its development into liver fibrosis or, further, liver cirrhosis. Since no ideal drug is available, liver fibrosis is currently considered to be a major worldwide health problem. A research conducted by by Dr. ZH Liu from Jilin University found that ARIP2 participates in the negative feedback regulation of signal transduction in the late stage by affecting the expression of ActRIIA, which further suggests that ARIP2 might be a potential target for treatment of liver fibrosis induced by activin.
   Similar news · Read more »
   
7. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
8. RAND to review renewable energy study and will issue corrected version
   12-05-2006 · EurekAlert!
   The RAND Corporation today announced that it is revising a study on renewable energy expenditures issued November 13 after learning there were some inadvertent errors in the computer model and numerical assumptions on which the study findings were based.
   Similar news · Read more »
   
9. Findings suggest current approach to drug discovery for Lou Gehrig's disease be re-examined
   05-07-2007 · EurekAlert!
   Most research on Lou Gehrig's disease therapeutics has been based on the assumption that its two forms (sporadic and hereditary) are similar in their underlying cause. Now, researchers at the University of Pennsylvania School of Medicine have found an absolute biochemical distinction between these two disease variants, suggesting that current approaches to drug discovery should be re-examined.
   Similar news · Read more »
   
10. OFT's value-based pricing scheme is well-founded, but could increase overall NHS drug spend
    05-29-2007 · EurekAlert!
    A report by the OFT has recommended that drug pricing is based not on how much the drug costs to develop, but on the benefit that the drug can bring. After examining the proposals for a paper in Health Economics, Professor Karl Claxton believes that such Value-Based Payments (VBP) make sense. However, he's worried that the current plan is overly generous toward pharmaceutical companies and could lead to a rise in the NHS's total bill.
    Similar news · Read more »